4//SEC Filing
Girao Tiago 4
Accession 0001209191-18-044206
CIK 0001095981other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:31 PM ET
Size
10.5 KB
Accession
0001209191-18-044206
Insider Transaction Report
Form 4
Girao Tiago
VP & Chief Financial Officer
Transactions
- Exercise of In-Money
Subscription Rights (Right to Buy)
2018-07-25−1→ 0 totalExercise: $1000.00From: 2018-06-29Exp: 2018-07-20→ See Footnote - Exercise of In-Money
Warrants (Right to Buy)
2018-07-25+1,050→ 1,050 totalExercise: $0.80Exp: 2021-01-25→ Common Stock (1,050 underlying) - Exercise of In-Money
Series C Preferred Stock
2018-07-25+1→ 1 totalExercise: $0.80From: 2018-07-25→ Common Stock (1,253 underlying)
Footnotes (3)
- [F1]The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the "Company") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units ("Units"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000.
- [F2]The Series C Preferred Stock has no expiration date.
- [F3]Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $0.7986 through January 25, 2021.
Documents
Issuer
CYTORI THERAPEUTICS, INC.
CIK 0001095981
Entity typeother
Related Parties
1- filerCIK 0001618670
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:31 PM ET
- Size
- 10.5 KB